We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

December 22, 2016

Securities and Exchange Commission v. Teva Pharmaceutical Industries Ltd.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 16, 2017

    Teva's Russian Subsidiary Pleads Guilty To FCPA Charge

    Generic-drug giant Teva Pharmaceutical's Russian subsidiary pled guilty Friday in Florida federal court to conspiring to violate the Foreign Corrupt Practices Act, and the judge indicated she will accept a sentence that involves a monitoring program and $519 million in payments imposed on the parent company through related cases.

2 other articles on this case. View all »

Parties

To view the parties, register now.